Oue et al[28] pointed out CK7-positivity and receipt of adjuvant chemotherapy tended to be beneficial for ESCC patients with stage II/III disease, and 20 (9%) of 225 ESCC cases were positive for CK7. This evidence concerns the gene KRT7 and esophageal squamous cell carcinoma.